• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年轻成年患者相比,老年患者特应性皮炎的临床特征和治疗管理:一项前瞻性多中心研究。

Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study.

机构信息

Department of Dermatology, University Hospital of Amiens, Amiens, France.

Department of Dermatology, Military Teaching Hospital Bégin, Saint Mandé, France; Dermatology, Private Practice, Saint-Maur-des-Fossés, France.

出版信息

Acta Derm Venereol. 2024 Sep 9;104:adv40420. doi: 10.2340/actadv.v104.40420.

DOI:10.2340/actadv.v104.40420
PMID:39248293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403363/
Abstract

Atopic dermatitis (AD) is the most common chronic inflammatory dermatitis in developed countries, and has a major impact on those affected. Little is known about AD in elderly patients. This prospective multicentre observational study described the clinical characteristics and burden of AD in elderly subjects ≥ 65 years, as well as the therapeutic options chosen for this population in routine care, and compared findings with those in young adults with AD < 30 years. Cohort data from adult patients with moderate-to-severe AD enrolled in a French national prospective registry (December 2020 to May 2023) were analysed. Patients ≥ 65 years made up 12.5% of the total adult cohort and presented less head-and-neck and extremity involvement, and were less affected by generalized forms than young adult patients. Elderly patients predominantly had late-onset AD and had similar disease severity to younger adults. Although the overall impact of AD appeared to be lower in elderly patients and treatment was initially less used in this age group, the substantial impact on sleep and psychiatric comorbidities was similar in older and younger adult patients. Better understanding of AD in elderly patients and the establishment of age-specific treatment guidelines may help dermatologists manage the disease in older people.

摘要

特应性皮炎(AD)是发达国家最常见的慢性炎症性皮肤病,对患者有重大影响。人们对老年患者的 AD 知之甚少。这项前瞻性多中心观察性研究描述了≥65 岁老年患者 AD 的临床特征和负担,以及在常规护理中为该人群选择的治疗方案,并将研究结果与<30 岁的年轻成人 AD 患者进行了比较。对法国全国前瞻性登记处(2020 年 12 月至 2023 年 5 月)中招募的中重度 AD 成年患者的队列数据进行了分析。≥65 岁的患者占成年患者总数的 12.5%,头颈部和四肢受累较少,全身受累的形式也少于年轻成人患者。老年患者主要为迟发型 AD,疾病严重程度与年轻成人患者相似。尽管 AD 对老年患者的总体影响似乎较低,且该年龄段的初始治疗使用较少,但对睡眠和精神共病的影响在老年和年轻成年患者中相似。更好地了解老年患者的 AD 并制定特定年龄的治疗指南可能有助于皮肤科医生管理老年人的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36ac/11403363/3ad83644be85/ActaDV-104-40420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36ac/11403363/e2e467ff362f/ActaDV-104-40420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36ac/11403363/3ad83644be85/ActaDV-104-40420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36ac/11403363/e2e467ff362f/ActaDV-104-40420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36ac/11403363/3ad83644be85/ActaDV-104-40420-g002.jpg

相似文献

1
Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study.与年轻成年患者相比,老年患者特应性皮炎的临床特征和治疗管理:一项前瞻性多中心研究。
Acta Derm Venereol. 2024 Sep 9;104:adv40420. doi: 10.2340/actadv.v104.40420.
2
Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.特应性皮炎疾病登记研究在日本中重度特应性皮炎(ADDRESS-J)成年患者中的应用:基线特征、治疗史和疾病负担。
J Dermatol. 2019 Apr;46(4):290-300. doi: 10.1111/1346-8138.14787. Epub 2019 Feb 13.
3
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease.一项关于成人特应性皮炎的意大利多中心研究:持续性疾病与成人发病型疾病。
Arch Dermatol Res. 2017 Aug;309(6):443-452. doi: 10.1007/s00403-017-1739-y. Epub 2017 Apr 21.
4
Characterizing Patients and Treatment Patterns in Moderate-to-severe Atopic Dermatitis in Finland: A Population-based Study Using National Health Data.芬兰中重度特应性皮炎患者特征及治疗模式:一项基于全国健康数据的人群研究
Acta Derm Venereol. 2025 Apr 24;105:adv41244. doi: 10.2340/actadv.v105.41244.
5
Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.儿童特应性皮炎的纵向控制和持续时间随发病时间而异:一项队列研究。
J Am Acad Dermatol. 2019 Dec;81(6):1292-1299. doi: 10.1016/j.jaad.2019.05.016. Epub 2019 May 11.
6
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.患有特应性皮炎接受系统治疗的成年人的疾病负担和治疗史:EUROSTAD 前瞻性观察研究参与者的基线特征。
J Dermatolog Treat. 2021 Mar;32(2):164-173. doi: 10.1080/09546634.2020.1866741. Epub 2021 Jan 18.
7
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.特应性皮炎患者接受系统治疗的疾病负担和患者特征:来自 CorEvitas 特应性皮炎登记研究的数据。
J Dermatolog Treat. 2024 Dec;35(1):2396382. doi: 10.1080/09546634.2024.2396382. Epub 2024 Sep 25.
8
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register.一项前瞻性观察性队列研究比较了环孢素、度普利尤单抗和甲氨蝶呤在成人和儿童特应性皮炎患者中的治疗效果和安全性:来自英国-爱尔兰 A-STAR 登记处的结果。
Br J Dermatol. 2024 Nov 18;191(6):988-999. doi: 10.1093/bjd/ljae287.
9
AtopyReg, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.特应性皮炎意大利成人中重度患者前瞻性登记研究(AtopyReg):基线人口统计学、疾病特征、合并症和治疗史。
Am J Clin Dermatol. 2024 Jan;25(1):149-160. doi: 10.1007/s40257-023-00819-y. Epub 2023 Sep 19.
10
[Translated article] Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry.[翻译文章] 特应性皮炎的临床流行病学概况以及与相关特应性合并症相关的治疗反应。来自BIOBADATOP注册研究的经验
Actas Dermosifiliogr. 2025 Apr;116(4):T337-T348. doi: 10.1016/j.ad.2025.02.014. Epub 2025 Feb 10.

引用本文的文献

1
Anti-Inflammatory Therapies for Atopic Dermatitis: A New Era in Targeted Treatment.特应性皮炎的抗炎疗法:靶向治疗的新时代。
J Clin Med. 2025 Jul 16;14(14):5053. doi: 10.3390/jcm14145053.
2
The Global Burden of Atopic Dermatitis in Elderly Populations: Trends, Disparities, and Future Projections.老年人群特应性皮炎的全球负担:趋势、差异及未来预测
Healthcare (Basel). 2025 Apr 1;13(7):788. doi: 10.3390/healthcare13070788.

本文引用的文献

1
Therapeutic inertia in the management of patients with inadequately controlled atopic dermatitis.特应性皮炎控制不佳患者管理中的治疗惰性
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e817-e818. doi: 10.1111/jdv.18303. Epub 2022 Jun 25.
2
Age-dependent Distribution of Atopic Dermatitis in Primary Care: A Nationwide Population-based Study from Finland.年龄相关性特应性皮炎在初级保健中的分布:来自芬兰的全国性基于人群的研究。
Acta Derm Venereol. 2022 Jun 15;102:adv00738. doi: 10.2340/actadv.v102.2287.
3
Real-world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire-based study.
真实世界中特应性皮炎患者生殖器湿疹的患病率和疾病负担:一项基于多中心问卷的研究。
J Dermatol. 2021 May;48(5):625-632. doi: 10.1111/1346-8138.15817. Epub 2021 Mar 5.
4
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.度普利尤单抗治疗老年特应性皮炎:一项多中心、真实世界研究。
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):958-964. doi: 10.1111/jdv.17094. Epub 2021 Jan 19.
5
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.欧洲皮肤病与性病学会/欧洲变态反应与临床免疫学会湿疹工作组2020年关于成人和儿童特应性皮炎诊断与治疗的立场文件。
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2717-2744. doi: 10.1111/jdv.16892. Epub 2020 Nov 17.
6
The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017.特应性皮炎的全球负担:1990 - 2017年全球疾病负担研究的经验教训
Br J Dermatol. 2021 Feb;184(2):304-309. doi: 10.1111/bjd.19580. Epub 2020 Nov 29.
7
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review.将老年人纳入特应性皮炎系统药物随机临床试验:系统评价。
JAMA Dermatol. 2020 Nov 1;156(11):1240-1245. doi: 10.1001/jamadermatol.2020.2940.
8
Prevalence and Incidence of Atopic Dermatitis: A Systematic Review.特应性皮炎的患病率和发病率:系统评价。
Acta Derm Venereol. 2020 Jun 9;100(12):adv00160. doi: 10.2340/00015555-3510.
9
Adult-Onset Atopic Dermatitis: Presentations and Progress.成人特应性皮炎:临床表现与进展。
J Cutan Med Surg. 2020 May/Jun;24(3):267-272. doi: 10.1177/1203475420911896. Epub 2020 Apr 2.
10
The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.成人特应性皮炎患者报告的疾病负担:欧洲和加拿大的一项横断面研究。
J Eur Acad Dermatol Venereol. 2020 May;34(5):1026-1036. doi: 10.1111/jdv.16003. Epub 2020 Jan 14.